Albert Smith, MD
Neurology · Salt Lake City, UTNPI 1548277197
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $79,020 of the $121,542 with a category attached, or 65.0%. 8 manufacturers reported payments, led by AstraZeneca at 53.2% of the total. 2025 is the largest year on record at $42,971, 4.2 times the $10,154 reported in 2019. Among neurology clinicians in UT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 122 payments — averaging $996.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$65K
- UCB, Inc.$26K
- Argenx US, Inc.$16K
- Vertex$10K
- Janssen Scientific Affairs, LLC$3K
- Merz Pharmaceuticals, LLC$2K
- plus $62 from 2 others
Across 1 payment — averaging $6558.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$7K
What the payments were for
- Consulting fees$29,16524%
- Speaking & faculty fees$79,02065%
- Travel & lodging$9,7688%
- Food & beverage$3,5903%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 53 | $64,703 |
| UCB, Inc. | 25 | $26,331 |
| Argenx US, Inc. | 25 | $15,617 |
| Vertex | 12 | $9,693 |
| Janssen Scientific Affairs, LLC | 4 | $2,764 |
| Merz Pharmaceuticals, LLC | 1 | $2,373 |
| Catalyst Pharmaceuticals, Inc. | 1 | $40 |
| Acist Medical Systems, Inc. | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$121,542 in reported general payments places this provider in the 90th percentile of 157 neurology providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FirdapseAmifampridine Phosphate | 32 | $1,386,923 |
| PrivigenImmun Glob G(Igg)/Pro/Iga 0-50 | 11 | $83,386 |
| Mycophenolate Mofetil | 22 | $12,031 |
| Gabapentin | 20 | $331 |
| Pregabalin | 11 | $319 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Catalyst Pharmaceuticals, Inc.Firdapse | $40 | $1,386,92332 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 157 neurology providers in Utah.
Other neurology in Salt Lake City
- Timothy WestSalt Lake City$856K
- Stacey SteevesSalt Lake City$548K
- Amir ArainSalt Lake City$329K
- Mark BrombergSalt Lake City$265K
- April ErwinSalt Lake City$263K
- John FoleySalt Lake City$99K
- Kevin BrennanSalt Lake City$81K
- Lucy DewittSalt Lake City$81K
- Nicholas JohnsonSalt Lake City$80K
- Viktoria KaplanSalt Lake City$58K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.